Study tests a blood test pattern in children with sepsis
Part of Immune system & allergy, Infections clinical trials.
This trial studies how a specific pattern in blood (called “molecular fingerprinting”) changes in children with suspected or developing sepsis. The goal is to help doctors better recognize sepsis early and understand how it progresses, which may improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 1 and 18 years old
- Be in the pediatric intensive care unit (PICU) for suspected sepsis or developing sepsis
- Start study enrollment from the time you arrive at the emergency department (ED), and be enrolled within 24 hours after starting sepsis antibiotics
- You (or your parent/guardian) must be able to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This study looks at a specific blood protein level in children from birth to age 17. It compares healthy children and those with sepsis to see if the protein changes during infection.
This trial is testing a new tool that uses artificial intelligence and biomarkers (substances in your blood) to help doctors recognize sepsis earlier. If you have been diagnosed with sepsis or are suspected of having it, this study may help improve how quickly and accurately it's detected.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
Hear when a new Systemic Inflammatory Response Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.